Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Safety and Efficacy of Apixaban in Very Old Geriatric Subjects (> 80 Years) With Atrial FIbrillation in a Prospective reAl World Study;

NCT04586972 is registered in ClinicalTrials.gov with Gérond'if as lead sponsor.

NCT NCT04586972
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT04586972 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Safety and Efficacy of Apixaban in Very Old Geriatric Subjects (> 80 Years) With Atrial FIbrillation in a Prospective reAl World Study;
Lead sponsor
Gérond'if
Phase
Observational
Overall status
Completed
Start date
September 23, 2020
Completion date
April 29, 2024
Enrollment
977 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

nonvalvular atrial fibrillation